Intensive chemotherapy vs venetoclax/hypomethylating agents for patients aged 60 to 75 years with favorable, NPM1-mutated AML.

For example, although the difference in WBC between treatment groups did not reach statistical significance, the IC group had nearly double the median WBC compared to the VEN/HMA group.

also in 111,027 other papers